A rat knockout model implicates TRPC4 in visceral pain sensation.

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Over 100 million Americans suffer from acute and chronic pain annually, significantly impacting mental health and quality of life.
• Numerous ion channels involved in pain signaling lack structural and functional characterization, representing unmet therapeutic targets.
• The Transient Receptor Potential Canonical subfamily 4 (TRPC4) ion channel regulates intracellular calcium signaling and is implicated in various physiological processes.

Purpose of the Study:

• To investigate the role of the TRPC4 ion channel in the detection and transmission of visceral pain.
• To evaluate the therapeutic potential of TRPC4 antagonists for managing visceral pain.

Main Methods:

• Utilized a rat model with a transposon-mediated TRPC4-knockout mutation.
• Administered a selective TRPC4 antagonist (ML-204) to wild-type rats.
• Assessed pain behaviors in response to colonic, somatic, and neuropathic pain stimuli, including mustard oil (MO) exposure.

Main Results:

• TRPC4-knockout rats exhibited tolerance to colonic MO-induced visceral pain but not somatic or neuropathic pain.
• Administration of ML-204 to wild-type rats replicated the pain tolerance observed in TRPC4-knockout rats.
• ML-204 demonstrated dose-dependent inhibition of visceral pain behavior without significant adverse effects.

Conclusions:

• TRPC4 ion channels are essential for the sensation of colonic visceral pain.
• TRPC4 signaling represents a promising therapeutic target for developing novel, non-addictive treatments for visceral pain.
• TRPC4 inhibitors may offer a safer alternative to opioid-based pain management strategies.